Showing results (1-10 of 338) with videos related to
Sort By:
Pageof 34
Future Cardiology|February 4, 2021
Canagliflozin: metabolic, cardiovascular and renal protectionVivencio Barrios, Carlos EscobarExpert Opinion on Drug Safety|August 19, 2011
Candesartan in the treatment of hypertension: what have we learnt in the last decade?Vivencio Barrios, Carlos EscobarExpert Opinion on Pharmacotherapy|May 8, 2010
Beating the clock: reducing cardiovascular risk by rapid blood pressure reduction with olmesartanVivencio Barrios, Carlos EscobarExpert Review of Cardiovascular Therapy|June 13, 2015
Edoxaban in the prevention and treatment of thromboembolic complications from a clinical point of viewVivencio Barrios, Carlos EscobarExpert Review of Cardiovascular Therapy|February 15, 2013
Rivaroxaban: a once-daily anticoagulant for the prevention of thromboembolic complicationsVivencio Barrios, Carlos EscobarCardiovascular & Hematological Agents in Medicinal Chemistry|March 10, 2010
Aliskiren: a new drug for an old problemVivencio Barrios, Carlos EscobarFuture Cardiology|December 15, 2015
Improving cardiovascular protection: focus on a cardiovascular polypillVivencio Barrios, Carlos EscobarExpert Review of Cardiovascular Therapy|November 25, 2010
Valsartan-amlodipine-hydrochlorothiazide: the definitive fixed combination?Vivencio Barrios, Carlos EscobarExpert Review of Cardiovascular Therapy|November 27, 2010
Antihypertensive and organ-protective effects of benazeprilVivencio Barrios, Carlos EscobarIntegrated Blood Pressure Control|August 28, 2014
Which thiazide to choose as add-on therapy for hypertension?Vivencio Barrios, Carlos EscobarPageof 34